Benefits Think Producers beware: CAA amplifies litigation risks
Health plan sponsors must know the direct and indirect compensation paid to benefit brokers, consultants and medical and prescription drug claims administrators.
Benefits Think Employers must follow the evidence when it comes to covering obesity medications
Supporting the health of employees can help prevent serious chronic conditions, and the financial impact that comes along with them.
Benefits Think ‘Eye’ spy a savings opportunity for health and vision benefits
Vision loss among workers results in $48 billion in lost productivity per year.
Benefits Think Why Trump’s drug plan fails employers
By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.
Benefits Think Why Trump’s drug plan fails employers
By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.
Biosimilars: What employers need to know
Novartis Zarxio is the first biosimilar product approved in the United States, ushering in a new era for the drug industry, consumers and third parties who manage medical and drug benefits.